Lobular Breast Cancer Alliance 2023
Lobular Breast Cancer Alliance 2023
  • Видео 64
  • Просмотров 60 319
Interview with LBCA’s Newest Scientific Advisory Board (SAB) member, Dr. Rimawi
LBCA Executive Director, Laurie Hutcheson interviewed our newest SAB member Dr. Rimawi to talk about his work in breast cancer research. Dr. Rimawi is a board-certified medical oncologist and translational clinical researcher, the Associate Director for Clinical Affairs and Executive Medical Director of the Dan L Duncan Comprehensive Cancer Center at the Baylor College of Medicine. His research focuses on translation of preclinical discoveries by conducting biologically rational, biospecimen-intense targeted therapy clinical trials with associated tissue-based biomarker studies. He discovered and developed several biomarkers of response and resistance to therapy in breast cancer making hi...
Просмотров: 112

Видео

Hear from Dr. Marina Sharifi, recipient of the SNMMI - LBCA ILC Imaging Research Fellowship
Просмотров 9314 дней назад
Dr. Marina Sharifi, MD, PhD, was announced in March as the recipient of the inaugural Society of Nuclear Medicine and Molecular Imaging (SNMMI) and LBCA Invasive Lobular Carcinoma (ILC) Imaging Research Fellowship. Dr. Sharifi is an assistant professor in the Department of Medicine, Division of Hematology, Oncology and Palliative Care at the University of Wisconsin, Madison, and received the $1...
Why Clinical Trial Participation is Important to Advance Breast Cancer Treatment
Просмотров 3742 месяца назад
In this video, "Why Clinical Trial Participation is Important to Advance Breast Cancer Treatment," LBCA Executive Director, Laurie Hutcheson discusses the importance of participating in clinical trials to help in the discoveries of new treatments for breast cancer, along with Dr. Jason Mouabbi, Chair of the LBCA Scientific Advisory Board, breast cancer patients and patient advocates. Also discu...
LBCA Lobular Breast Cancer Chat: Biomarkers as Tools in ILC
Просмотров 7412 месяца назад
LBCA held a Lobular Breast Cancer Chat: Biomarkers as tools in ILC, LBCA Scientific Advisory Board member Dr. Peter Simpson and his colleague Dr. Amy McCart Reed from the University of Queensland discussed biomarkers and their importance in ILC research. Topics covered include how biomarkers aid in research, the different types and ongoing biomarker discoveries. They also reviewed the context b...
LBCA Announces 2nd Local Advocacy Team (LAT) - Meet LAT DMV (D.C, Maryland & Virginia)
Просмотров 772 месяца назад
LBCA has launched its second Local Advocacy Team, or LAT, for patients with ILC, in Washington, D.C.. LBCA’s Local Advocacy Team Coordinator Kathleen Moss recently interviewed the newest organizers LAT Ambassadors, Brenda Sulick and Jeanette Brown, to discuss their new Local Advocacy Team.
Honoring Dr. Deborah Mueller - A Tribute Video
Просмотров 3162 месяца назад
Three ILC research grants were funded in 2024 by the Deborah Mueller Foundation in memory of LBCA board member Dr. Deborah Mueller who passed away precipitously in early 2023 from metastatic lobular breast cancer. Deborah's family have pledged their ongoing support for LBCA in keeping with her wishes. Her husband John recalls her as a “master surgeon, inspirational leader, mentor and an amazing...
LBCA Interviews new Scientific Advisory Board Member Dr. Rebecca Shatsky
Просмотров 3373 месяца назад
LBCA Patient Advocate and founding member Julia Levine interviews our newest Scientific Advisory Board (SAB) member Dr. Rebecca Shatsky.
LBCA Welcomes New Board Member Brenda Cunnington
Просмотров 1204 месяца назад
The Lobular Breast Cancer Alliance welcomes new member to the Board of Directors, Brenda Cunnington. Brenda is interviewed by LBCA Executive Director, Laurie Hutcheson about her decision to get involved.
LBCA Announces First Local Advocacy Team
Просмотров 1524 месяца назад
The Lobular Breast Cancer Alliance has launched its first Local Advocacy Team for patients with ILC. Executive Director Laurie Hutcheson and Advocacy Group Coordinator Kathleen Moss interview the organizers of Lobular Awareness Network of South Carolina to discuss the purpose and mission of the new team.
ILC Symposium 2023: Research Poster Interview with Baylee Porter, PhD
Просмотров 3717 месяцев назад
Baylee Porter, PhD, discusses her poster Glucocorticoid Receptor Activation Inhibits Tumor Cell Growth While Increating Metastatic Characteristics in Model of Invasive Lobular Carcinoma.
Highlights of 2023 International ILC Symposium
Просмотров 1,5 тыс.9 месяцев назад
On November 15, 2023, the Lobular Breast Cancer Alliance in partnership with the European Lobular Breast Cancer Consortium (ELBCC) presented Highlights of the 2023 International Invasive Lobular Carcinoma (ILC) Symposium. This educational webinar showcases lay summaries of presentations on ILC science given at September's conference in Pittsburgh, PA. PLEASE NOTE: We are not able to provide med...
Thank You from LBCA Scientific Advisors and ILC Research Grantees 2023
Просмотров 2269 месяцев назад
Drs. Fresia Pareja, George Sflomos, and Capucine Héraud, along with the staff of the Lobular Breast Cancer Alliance, wish everyone a happy and healthy holiday season.
ILC Symposium 2023: Research Poster Interview with Simran Sandhu
Просмотров 16610 месяцев назад
MD student Simran Sandhu discusses her poster Racial Disparities in Survival in Lobular Breast Cancer. Co-author of the poster is Lobular Breast Cancer Alliance past funded researcher Dr. David Lim.
LBCA Poster: Individuals with Invasive Lobular Carcinoma Raise Their Voices About ILC and Surgery
Просмотров 54511 месяцев назад
Lobular Breast Cancer Alliance (LBCA) Chair Dr. Tracy Cushing discusses the LBCA ILC poster presented at the 2023 ILC Symposium.
What's New in Screening and Treatment for Lobular Breast Cancer
Просмотров 8 тыс.11 месяцев назад
On September 12, 2023, the Lobular Breast Cancer Alliance (LBCA) hosted this live webinar that provided attendees with an opportunity to hear from three panelists who discussed the screening and treatment of invasive lobular carcinoma (ILC) from their specific clinical perspectives. First, Tali Amir, MD, from Memorial Sloan Kettering Cancer Center, shared information on ILC detection and survei...
LBCA Interview with Dr. George Sflomos 2023
Просмотров 579Год назад
LBCA Interview with Dr. George Sflomos 2023
Logan O'Connor Honors His Mother with Lobular Breast Cancer
Просмотров 618Год назад
Logan O'Connor Honors His Mother with Lobular Breast Cancer
Anna & Molly Burgess Honor Their Mother with Lobular Breast Cancer
Просмотров 425Год назад
Anna & Molly Burgess Honor Their Mother with Lobular Breast Cancer
Nila Vaseghi Honors Her Mother with Lobular Breast Cancer
Просмотров 935Год назад
Nila Vaseghi Honors Her Mother with Lobular Breast Cancer
Angela Stanford Honors Her Mother Nan
Просмотров 357Год назад
Angela Stanford Honors Her Mother Nan
Tanya Martin-Dick Honors Her Mother with Lobular Breast Cancer
Просмотров 476Год назад
Tanya Martin-Dick Honors Her Mother with Lobular Breast Cancer
LBCA Advocate Chat: Results from a Population Based Lobular Breast Cancer Study in Ontario, Canada
Просмотров 517Год назад
LBCA Advocate Chat: Results from a Population Based Lobular Breast Cancer Study in Ontario, Canada
LBCA Advocate Chat: Introduction to Cancer Basic Science and Immunology
Просмотров 624Год назад
LBCA Advocate Chat: Introduction to Cancer Basic Science and Immunology
Appropriate Use Criteria for Fluoroestradiol
Просмотров 436Год назад
Appropriate Use Criteria for Fluoroestradiol
LBCA Advocate Chat: Discussion with Jason Mouabbi of Several ILC Posters at SABCS22
Просмотров 1,1 тыс.Год назад
LBCA Advocate Chat: Discussion with Jason Mouabbi of Several ILC Posters at SABCS22
LBCA Advocate Chat: Conducting a Peer-to-Peer Fundraiser
Просмотров 48Год назад
LBCA Advocate Chat: Conducting a Peer-to-Peer Fundraiser
Thank You from LBCA Scientific Advisory Board 2022
Просмотров 136Год назад
Thank You from LBCA Scientific Advisory Board 2022
LBCA Interview with Rinath Jeselsohn, MD: Understanding the Features of the Estrogen Receptor in ILC
Просмотров 1 тыс.Год назад
LBCA Interview with Rinath Jeselsohn, MD: Understanding the Features of the Estrogen Receptor in ILC
LBCA Advocate Chat:How We Know What We Know About Cancer Data
Просмотров 194Год назад
LBCA Advocate Chat:How We Know What We Know About Cancer Data
Highlights of 2022 ILC Intl Symposium
Просмотров 2 тыс.Год назад
Highlights of 2022 ILC Intl Symposium

Комментарии

  • @zaferaksit2009
    @zaferaksit2009 39 минут назад

    IHC (immunohistochemical) biomarkers do not really work, show true prognosis, in ILC or the correct term BCMO (BC of mesenchymal origin). Please look into this issue.

  • @zaferaksit2009
    @zaferaksit2009 4 дня назад

    In ref. to the Q&A’s, it should be the radiologist who calls the shots on whıch imaging modalities to use for the patients benefit in search for the patients treatment and thus prognosis.

  • @zaferaksit2009
    @zaferaksit2009 4 дня назад

    İn ‘ILC’, it could be postulated, that metastasis is different, due to its interstitial space invation. No tumor “adherence”.

  • @zaferaksit2009
    @zaferaksit2009 4 дня назад

    We can see that the immunehistochemical (IHC) analysis of ‘ILC’ does not predict the ‘outcome’ of ‘ILC’, where it is shown to be “Luminal A”.

  • @zaferaksit2009
    @zaferaksit2009 4 дня назад

    İt is great that women are taking a stand on the issue of ‘difficult to diagnose’ breast cancers (BC). I would very much urge your groupe to ask the doctors you are in contact, to convay to you the latest articles (articles in the EJR of the last 2 years) of Dr. Laszlo Tabar on ‘ILC’, where different prognosis is shown for the different 2 types of ‘ILC’, which are mesenchymal tumors in origin who are comprized of stem cells, where the pathological report is so crutial in the outcome. You could ask Dr. Tabar himself to explain his statistics of 39 years duration.

  • @RoseGarden86
    @RoseGarden86 Месяц назад

    I don't feel very hopeful after watching this video but admire all the oncologists and oncology researchers for working in this field because oncology is one of those fields that the more you learn the less you know and it can get frustrating sometimes. Keep going and keep researching and blessings to you all 🙏

  • @RoseGarden86
    @RoseGarden86 Месяц назад

    Thank you for sharing Deborah`s story. May she rest in peace. I keep hearing stories of patients being classified as stage 1 or 2 but then it`s discovered few months later that it is stage 4 MBC specially in ILC. Doctors are very hesitant to order CT and PET scans due to insurance issues, but I think it`s something that patients should advocate for during the early stages of diagnosis

  • @sherylappelbaum5305
    @sherylappelbaum5305 2 месяца назад

    I found out when I was 62 that I have a fantastic doctor Dr. Nicholas Tranakas, MD Fort Lauderdale Florida. He found ILC right under the nipole stage 1. I had a double mastectomy on 12/28/22 no reconstruction. How come the doctors do not do ultrasounds after double mastectomy? I am on anastrozole they removed the cancer no lymph nodes involvement. Thank you.

  • @RoseGarden86
    @RoseGarden86 2 месяца назад

    Do blood tests ( Invitae & Signatera ) only used in metastatic setting or can it be used for early-stage breast cancer as well to monitor reoccurrence?

  • @kaypitts2158
    @kaypitts2158 2 месяца назад

    Thank you for sharing this story. My daughter age 45 at the time was dx with stage IIIB Lobular Breast cancer. She had a double mastectomy, reconstruction, radiation and chemotherapy in 2019-2020. She is on long term hormone therapy and doing well at this time under the care of doctors at Johns Hopkins. Your story of your wife being diagnosed Stage I lobular breast Cancer with Metastasis to her liver within one year is very scary. I am so sad to have heard this. We are very blessed that our daughter has received excellent care and is doing well. God Bless.

  • @Lisa-xp5qj
    @Lisa-xp5qj 2 месяца назад

    Excellent lecture!! thank you!

  • @SabineSSpitz
    @SabineSSpitz 3 месяца назад

    A great video. Thank you very much.

  • @margaretgremore9175
    @margaretgremore9175 3 месяца назад

    How refreshing to hear an oncologist state that ILC is misunderstood. My doctors keep telling me that it should be treated the same as ductal cancer. They insist that a standard mammogram is the “gold standard” for surveillance. Not only have I had a partial mastectomy for ILC diagnosis, I also have heterogeneous dense breasts. I have had to fight very hard for MRI’s. No matter how much advocacy I do for myself I feel I am as misunderstood as my disease.

  • @shuszie
    @shuszie 4 месяца назад

    I just had a mastectomy after diagnosis of Invasive Lobular Carcinoma .. with no lymph invasions .. twelve years after having a lumpectomy .. so I am back with five years of oestrogen blockers again! … at 77 years old! My symptoms were on the scar of the lumpectomy .. out front thankfully. All good

  • @user-vu7vr7lb1j
    @user-vu7vr7lb1j 4 месяца назад

    Thank you all for your valuable work. LBCA is such an important organization .

  • @estrogendiaries
    @estrogendiaries 4 месяца назад

    Thanks so much for your crucial contribution to this team, Brenda! I look forward to meeting you in person someday.

  • @estrogendiaries
    @estrogendiaries 4 месяца назад

    Minnie spoke about how important the ILC Symposium was for her-all of the sessions are here on RUclips from that symposium if you search for “ILC Symposium”!

  • @mamatheshkumar5711
    @mamatheshkumar5711 5 месяцев назад

    adenoma myoma lipoma lymphoma neuroma. hail the lord !

  • @yorkiepeachygirlllc761
    @yorkiepeachygirlllc761 6 месяцев назад

    What's the long term effectiveness of Tamoxifen for POST menopausal women with DMX.?

  • @Tamawarren
    @Tamawarren 7 месяцев назад

    Wonderful research. What is most effective way to get GR increase in our body. This is so fantastic. Thank you for your incredible research and hard work to save lives and learn more about this lobular cancer.

  • @kathybordick40
    @kathybordick40 9 месяцев назад

    This was so informative. I loved seeing my surgeon again...Dr McAuliffe. She speaks to precisely and clearly.

  • @slaneymullen4870
    @slaneymullen4870 9 месяцев назад

    Thanks for all the information and the hard work you do for ILC research Looking forward to target therapy via wgs of tumour!? Great you highlighted tamoxifen still works I changed to tamoxifen after trying a couple AIs Feet and hands collapsed and felt like an old women over night Keeping fit is more important than staying on an ai For me Because Being able to Lift weights and do loads of zone 2 Gives me such joy

  • @libbyneves5457
    @libbyneves5457 10 месяцев назад

    In 2006 was diagnosed with an “Invasive lobular tumor encased in dense breast tissue”. I think a key towards diagnosis is to educate the public about how a Lobular tumor may present. My tumor formed in a breast that contained several benign cysts around the nipple. The cysts became large and painful, with the rest of my general bilateral breast tissue, before every period. At some point, my right breast had heavy tissue deeper in that breast. The tissue had a sloppy feel, and got more painful before and after every period. I also began having a heavy period every two weeks. After every period this dense tissue git bigger and bigger. I NEVER KNEW THAT BREAST CANCER COULD BE ANYTHING BESIDES A LUMP. I NEVER KNEW FREQUENT PERIODS WERE A SYMPTOM OF BREAST CANCER. I NEVER KNEW THAT BREAST CANCER COULD BE PAINFUL. That tumor was six centimeters by the time I had a diagnosis. I went to a major teaching university for treatment: chemo first to shrink the tumor , a total mastectomy with sentinel node biopsy while I was on the table, a saline implant in the same operation. I never had scans to find metastasized tumors. I didn’t ask, but still assume that if the chemo didn’t each any metastasis, I would be a goner anyway. By the time I was diagnosed, I could feel the weight of the tumor pulling in my arm pit. The Sentinel Node biopsy located eleven arm pit lymph nodes attached to the tumor. Three were positive. The chemo I had was Adriamycin, Cytoxin (4 infusions two weeks apart) and Taxol (4 infusions two weeks apart). My hormone markers were highly estrogen and progesterone positive. I had been using a compounded progesterone cream on that breast to reduce pre-period pain. I had also been thumped on that breast by a man at a Christmas party 18 months before the diagnosis. Now I understand why women in Wagner’s operas wear metal bras. A nurse told me that my chemo was The Gold Standard for estrogen positive breast cancer. I don’t know if chemo prescriptions are different for lobular or not. I didn’t work or drive for six months through my treatment. The chemo was tough, but I had to do all I could to live. I was very self-centered about my needs, and my family was totally on board with helping me. I hope this helps someone get an earlier diagnosis. And that thump? He didn’t leave a bruise, so I didn’t go to the police at the time. Law enforcement has a machine that can find sub-dermal bruising, however.

  • @carebear6069
    @carebear6069 10 месяцев назад

    Why does no one discuss Metabolic Therapy as an adjuvant treatment?

  • @user-hh8xs8fq6i
    @user-hh8xs8fq6i Год назад

    Cheers to you doctor osagh, I celebrate the way you do your job. If it was up to me I would give you the award of being the best herbal doctor. Thank you for cureing me from cancer with your herbal medication am so grateful........😘😘

  • @normallynorma7621
    @normallynorma7621 Год назад

    Diagnosed over 5 years ago with ILC no surgery no drugs, I was told in Jan 2020 that I would be gone in 6 months, still here. I BELIEVE OXALATES are a BIG part, but nobody wants to talk about it. I stay away from pHARMa Doctors now! Believe in yourself!

  • @IamChezzerella
    @IamChezzerella Год назад

    Just diagnosed with ILBC keep up the good work ladies. We out here appreciate you both. Thank you

  • @suzannebissell5894
    @suzannebissell5894 Год назад

    Great info! Thank you!

  • @aliciajohn495
    @aliciajohn495 Год назад

    I was just recently diagnosed with ILC Breast Cancer and I am only 39 and I am a single mother with four children. If you have any advice or help with this please let me know.

  • @jenniferrobinson8698
    @jenniferrobinson8698 Год назад

    Thank you for putting this session together. Excellent discussions with Dr Mouabbi & the advocates.

  • @CHERYLSTIME23
    @CHERYLSTIME23 Год назад

    Thank you. I have invasive lobular carcinoma went thru 3 surgeries lumpectomies then radation will begin but before I started radiation I found out that the specimen surgeon sent in was just what the pathologist could view. I am 64 this all started at 63 but even fast going in treatment I was alone the whole time I have a little dog she's precious. But I remain positive Only God could have pulled me thru. Long long different struggle. Cancer changed my entire being just different I am. Again thank you I appreciate The Invasive Lobular Carcinoma breast cancer isn't studied enough We need more study. I feel as a ILC that yes more study should be put first and foremost.

  • @LadyD1979
    @LadyD1979 Год назад

    The one i have formed a nodule. Weird. Its more than one tho

  • @nickylee1408
    @nickylee1408 Год назад

    I had lobular breast cancer dec 2011,stage 3 grade 3

  • @marymazzoni2079
    @marymazzoni2079 Год назад

    So Does that mean aromatase inhibitors seem to work better with lobular breast cancer ?

  • @knottsmarilyn
    @knottsmarilyn Год назад

    Thanks

  • @nickylee1408
    @nickylee1408 Год назад

    I was diagnosed lobular breast cancer 2011,stage 3,mastectomy rads,I begged my doctor to remove other breast but refused to do it he said I was high risk for it to return I live in fear. From 🇬🇧.

  • @estrogendiaries
    @estrogendiaries Год назад

    Is this study open to women who have had ILC and then had a double mastectomy? Or do you need to have a breast still intact to qualify for the study? From the images shown here, it looks like they are looking to ID longer term systemic spread...?

    • @LobularBreastCancerAlliance
      @LobularBreastCancerAlliance Год назад

      Hello. Here is more information on the trial and contact information so you can ask the questions directly to them. Good luck! lobularbreastcancer.org/imaging-trial-18f-fluoroestradiol-fes-pet-ct-for-breast-cancer/

  • @vanessacampbell4655
    @vanessacampbell4655 Год назад

    Really couldn't hear what she said with all the beautiful birds singing in the background except she lives in Italy for the last 30 years.

    • @LobularBreastCancerAlliance
      @LobularBreastCancerAlliance Год назад

      Yes, it was done on site outside where the symposium was held. We did our best with the natural sound.

  • @caunteya
    @caunteya 2 года назад

    My sister is diagnosed with ILC with ER+, but why did the radiologist performed an FDG PET scan instead of FES scan?

  • @mandypaige9387
    @mandypaige9387 2 года назад

    Why is lobular breast cancer hard to see on imaging. Does it get mistaken for benign pathology.

    • @LobularBreastCancerAlliance
      @LobularBreastCancerAlliance 2 года назад

      Hi Mandy. Here is our FAQ. That question and more are answered in it. Hope it helps. lobularbreastcancer.org/faq/

  • @caunteya
    @caunteya 2 года назад

    Really appreciate your work. You are doing god's work.

  • @billytheweasel
    @billytheweasel 2 года назад

    Invasive lobular carcinoma seems to be ignored even though it's the 2nd most common breast cancer.

  • @pbo8428
    @pbo8428 2 года назад

    I have lobular breast cancer with signet ring cell features and was diagnosed last year in 2021. My surgeon called me lucky because I was the one that found the two tumors in my right breast. Imaging from the mammogram was unable to depict a clear view of them because of my dense breast tissue. Thank you for creating and advocating the need to have more research.

    • @caunteya
      @caunteya 2 года назад

      Wish you a long and healthy life

  • @Sarappreciates
    @Sarappreciates 2 года назад

    I was told about "scarier cancers" than my invasive ductal carcinoma. I feel fortunate to have a type of cancer that gets loads of funding, so it's manageable. They were even gonna CURE me (not remission, but a CURE) before they found out it's metastatic. Lobular breast cancer needs the same kind of love. It feels so unfair to have treatments and even cures for "these cancers" but not for "those cancers." I know it's probably more complicated than just fairness, but I want a better chance for ALL cancer patients! Thank you for the work you're doing. You're going to extend many lives (and the quality of those lives) with your research!

  • @viorelscrob6391
    @viorelscrob6391 2 года назад

    My mom had ovarian cancer it's tied. ?

  • @user-uy4wo3xv9o
    @user-uy4wo3xv9o 2 года назад

    An excellent video and I hope many investigators will look this video

  • @daniellosen4008
    @daniellosen4008 2 года назад

    An excellent video highlighting the need for more research!

    • @billytheweasel
      @billytheweasel 2 года назад

      Immunotherapy. I hope they come up with a monoclonal antibody treatment and/or combination treatment.

  • @gregoryramsey8213
    @gregoryramsey8213 2 года назад

    My gf has stage 2a breast cancer, Er+/HER-2 negative, with three positive lymph nodes with high percentages of estrogen and progesterone. She is 37, has oncotype score of 6, distant reoccurrence score at 11%, with no apparent benefit with chemo. Her ki67 is 7% and her blood work is 19 U/mL. She is planning on doing ovarian suppression. She is grade 2. She had nipple reserving double mastectomy. She’s very healthy. Her mother and grandmother had breast cancer. I know chemo suppresses ovaries (and helps by 5%), but she doesn’t want it. Would adjuvant endocrine therapy be recommended on these results?